Homologous or heterologous COVID-19 vaccine schemes: comparison of immune responses and side effects.

Autor: Karaali R; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Öykü Dinç HÖ; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Bezmialem Vakıf University Istanbul Istanbul, Turkey., İnanç Balkan İ; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Can G; Department of Public Health, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Keskin E; Department of Medical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul Turkey., Çolak H; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Daşdemir FO; Department of Medical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul Turkey., Aydoğan O; Department of Medical Microbiology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey., Budak B; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Kaya SY; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Kocazeybek B; Department of Medical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul Turkey., Saltoğlu N; Department of Infectious Diseases and Clinical Microbiology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey. Electronic address: saltoglu.nese@gmail.com.

Publikováno v: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2023 Oct; Vol. 107 (2), pp. 116017. Date of Electronic Publication: 2023 Jul 07.